Terms: = Uterine cancer AND TFRC, P02786, 7037, ENSG00000072274, TFR1, CD71 AND Treatment
6 results:
1. Transferrin receptor modulated by microRNA-497-5p suppresses cervical cancer cell malignant phenotypes.
Fang X; Hu P; Gao Y; Chen C; Xu J
Adv Clin Exp Med; 2024 Mar; 33(3):273-282. PubMed ID: 37486696
[TBL] [Abstract] [Full Text] [Related]
2. A Novel Immune-Related Signature to Predict Prognosis and Immune Infiltration of Cervical cancer.
Lin Y; Zhang R; Pan H; Li Y
Med Sci Monit; 2023 Mar; 29():e938660. PubMed ID: 36973995
[TBL] [Abstract] [Full Text] [Related]
3. Iron metabolism protein transferrin receptor 1 involves in cervical cancer progression by affecting gene expression and alternative splicing in HeLa cells.
Huang N; Wei Y; Cheng Y; Wang X; Wang Q; Chen D; Li W
Genes Genomics; 2022 Jun; 44(6):637-650. PubMed ID: 35066810
[TBL] [Abstract] [Full Text] [Related]
4. cd71
Leung TH; Tang HW; Siu MK; Chan DW; Chan KK; Cheung AN; Ngan HY
Mol Cancer Res; 2019 Sep; 17(9):1867-1880. PubMed ID: 31235657
[TBL] [Abstract] [Full Text] [Related]
5. Desferal regulates hCtr1 and transferrin receptor expression through Sp1 and exhibits synergistic cytotoxicity with platinum drugs in oxaliplatin-resistant human cervical cancer cells in vitro and in vivo.
Chen SJ; Kuo CC; Pan HY; Tsou TC; Yeh SC; Chang JY
Oncotarget; 2016 Aug; 7(31):49310-49321. PubMed ID: 27384479
[TBL] [Abstract] [Full Text] [Related]
6. First study of oral Artenimol-R in advanced cervical cancer: clinical benefit, tolerability and tumor markers.
Jansen FH; Adoubi I; J C KC; DE Cnodder T; Jansen N; Tschulakow A; Efferth T
Anticancer Res; 2011 Dec; 31(12):4417-22. PubMed ID: 22199309
[TBL] [Abstract] [Full Text] [Related]